Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.

Butler, Javed; Anker, Stefan D; Filippatos, Gerasimos; Khan, Muhammad Shahzeb; Ferreira, João Pedro; Pocock, Stuart J; Giannetti, Nadia; Januzzi, James L; Piña, Ileana L; Lam, Carolyn SP; +11 more... Ponikowski, Piotr; Sattar, Naveed; Verma, Subodh; Brueckmann, Martina; Jamal, Waheed; Vedin, Ola; Peil, Barbara; Zeller, Cordula; Zannad, Faiez; Packer, Milton; EMPEROR-Reduced Trial Committees and Investigators; (2021) Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial. European heart journal. ISSN 0195-668X DOI: https://doi.org/10.1093/eurheartj/ehaa1007

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/eurheartj/ehaa1007

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID 33420498
Elements ID 155413

Share

Download

Filename: ehaa1007.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar